- Home
- STKH vs ONVO Comparison
STKH vs ONVO Comparison
Compare STKH & ONVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STKH
- ONVO
- Stock Information
- Founded
- STKH 2018
- ONVO 2007
- Country
- STKH Israel
- ONVO United States
- Employees
- STKH N/A
- ONVO N/A
- Industry
- STKH Packaged Foods
- ONVO Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- STKH Consumer Staples
- ONVO Health Care
- Exchange
- STKH Nasdaq
- ONVO Nasdaq
- Market Cap
- STKH 8.1M
- ONVO 7.2M
- IPO Year
- STKH 2021
- ONVO N/A
- Fundamental
- Price
- STKH $2.44
- ONVO $0.42
- Analyst Decision
- STKH
- ONVO
- Analyst Count
- STKH 0
- ONVO 0
- Target Price
- STKH N/A
- ONVO N/A
- AVG Volume (30 Days)
- STKH 17.1K
- ONVO 102.4K
- Earning Date
- STKH 08-30-2024
- ONVO 11-26-2024
- Dividend Yield
- STKH N/A
- ONVO N/A
- EPS Growth
- STKH N/A
- ONVO N/A
- EPS
- STKH N/A
- ONVO N/A
- Revenue
- STKH N/A
- ONVO $103,000.00
- Revenue This Year
- STKH N/A
- ONVO $59.08
- Revenue Next Year
- STKH N/A
- ONVO $18.24
- P/E Ratio
- STKH N/A
- ONVO N/A
- Revenue Growth
- STKH N/A
- ONVO N/A
- 52 Week Low
- STKH $2.36
- ONVO $0.32
- 52 Week High
- STKH $7.70
- ONVO $1.74
- Technical
- Relative Strength Index (RSI)
- STKH 33.13
- ONVO 47.62
- Support Level
- STKH $2.54
- ONVO $0.39
- Resistance Level
- STKH $2.80
- ONVO $0.46
- Average True Range (ATR)
- STKH 0.17
- ONVO 0.05
- MACD
- STKH -0.03
- ONVO -0.00
- Stochastic Oscillator
- STKH 6.78
- ONVO 62.27
About STKH Steakholder Foods Ltd.
Steakholder Foods Ltd is a deep-tech food company. The company is cultivating meat technologies to improve meat production, simplify the meat supply chain, and offer consumers a range of new product offerings. The company aims to provide an alternative to industrialized animal farming that reduces carbon footprint, minimizes water and land usage, and prevents the slaughtering of animals. It is developing a novel, proprietary three-dimensional bioprinter for three-dimensional printing of meat and seafood analogs, followed by hybrid meats that combine cultivated and plant-based elements.
About ONVO Organovo Holdings Inc.
Organovo Holdings Inc is a biotechnology company focused on developing FXR314 in inflammatory bowel disease (IBD), including ulcerative colitis (UC), based on demonstration of clinical promise in three-dimensional (3D) human tissues as well as preclinical data. FXR is a mediator of gastrointestinal and liver diseases.